NO174806C - - Google Patents

Info

Publication number: NO174806C
Authority: NO; Norway
Prior art keywords: addition salts; bases; inorganic; compounds; general formula
Prior art date: 1990-11-02

Application number

NO914294A

Other languages

English (en)

Norwegian (no)

Other versions

NO914294L (no

NO174806B (no

NO914294D0 (no

Inventor

Frank Himmelsbach

Volkhard Austel

Helmut Pieper

Wolfgang Eisert

Thomas Muller

Johannes Weisenberger

Gunter Linz

Gerd Kruger

Original Assignee

Thomae Gmbh, Dr. Karl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-11-02

Filing date

1991-11-01

Publication date

1994-07-13

1991-11-01 Application filed by Thomae Gmbh, Dr. Karl filed Critical Thomae Gmbh, Dr. Karl

1991-11-01 Publication of NO914294D0 publication Critical patent/NO914294D0/no

1992-05-04 Publication of NO914294L publication Critical patent/NO914294L/no

1994-04-05 Publication of NO174806B publication Critical patent/NO174806B/no

1994-07-13 Publication of NO174806C publication Critical patent/NO174806C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Biochemistry (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyrrole Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)
Detergent Compositions (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

NO914294A 1990-11-02 1991-11-01 Analogifremgangsmåte for fremstilling av cykliske iminoderivater NO174806B (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4035961A DE4035961A1 (de)	1990-11-02	1990-11-02	Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Publications (4)

Publication Number	Publication Date
NO914294D0 NO914294D0 (no)	1991-11-01
NO914294L NO914294L (no)	1992-05-04
NO174806B NO174806B (no)	1994-04-05
NO174806C true NO174806C (cs)	1994-07-13

Family

ID=6418111

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO914294A NO174806B (no)	1990-11-02	1991-11-01	Analogifremgangsmåte for fremstilling av cykliske iminoderivater

Country Status (24)

Country	Link
US (2)	US5541343A (cs)
EP (1)	EP0483667B1 (cs)
JP (1)	JP2937589B2 (cs)
KR (1)	KR100223135B1 (cs)
AT (1)	ATE163008T1 (cs)
BG (1)	BG62025B2 (cs)
BR (1)	BR1100445A (cs)
CA (1)	CA2054850C (cs)
DE (2)	DE4035961A1 (cs)
DK (1)	DK0483667T3 (cs)
EE (1)	EE03099B1 (cs)
ES (1)	ES2113867T3 (cs)
FI (1)	FI107606B (cs)
GR (1)	GR3026508T3 (cs)
HU (2)	HUT67288A (cs)
IE (1)	IE913822A1 (cs)
IL (1)	IL99926A (cs)
MX (1)	MX9203677A (cs)
NO (1)	NO174806B (cs)
NZ (1)	NZ240463A (cs)
PT (1)	PT99402B (cs)
RU (1)	RU2040519C1 (cs)
SG (1)	SG81852A1 (cs)
ZA (1)	ZA918734B (cs)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4127404A1 (de) *	1991-08-19	1993-02-25	Thomae Gmbh Dr K	Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5294713A (en) *	1991-08-23	1994-03-15	Takeda Chemical Industries, Ltd.	2-piperazinone compounds and their use
DE4213919A1 (de) *	1992-04-28	1993-11-04	Thomae Gmbh Dr K	Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4213931A1 (de) *	1992-04-28	1993-11-04	Thomae Gmbh Dr K	Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DK0567967T3 (da) *	1992-04-28	1996-11-18	Thomae Gmbh Dr K	Tritium-mærkede fibrinogen-receptor-antagonister, deres anvendelse og fremgangsmåde til deres fremstilling
DE4219158A1 (de) *	1992-06-11	1993-12-16	Thomae Gmbh Dr K	Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4241632A1 (de) *	1992-12-10	1994-06-16	Thomae Gmbh Dr K	Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5314902A (en) *	1993-01-27	1994-05-24	Monsanto Company	Urea derivatives useful as platelet aggregation inhibitors
DE69425431T2 (de) *	1993-03-31	2001-02-08	G.D. Searle & Co., Chicago	1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
US6169107B1 (en)	1993-04-28	2001-01-02	Sumitomo Pharmaceutical Co., Ltd.	Indoloylguanidine derivatives
DE4424975A1 (de) *	1994-07-15	1996-01-18	Thomae Gmbh Dr K	2-Piperidinone, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
PL321003A1 (en) *	1994-12-23	1997-11-24	Thomae Gmbh Dr K	Derivatives of piperasine, drugs containing them, their application and methods of obtaining them
CA2216162A1 (en) *	1995-04-26	1996-10-31	Takeda Chemical Industries, Ltd.	Piperazinones useful as inhibitors of platelet aggregation
DE19515500A1 (de) *	1995-04-27	1996-10-31	Thomae Gmbh Dr K	Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5719296A (en) *	1995-10-30	1998-02-17	Merck & Co., Inc.	Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
DE19604191A1 (de) *	1996-02-06	1997-08-07	Hoechst Schering Agrevo Gmbh	2,4-Diamino-1,3,5-triazine, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
US5942544A (en) *	1996-02-22	1999-08-24	Dupont Pharmaceuticals Company	α-branched anilines, toluenes, and analogs thereof as factor Xa inhibitors
DE19621482A1 (de) *	1996-05-29	1997-12-04	Hoechst Ag	Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621483A1 (de) *	1996-05-29	1997-12-04	Hoechst Ag	Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JP2000516234A (ja) *	1996-08-16	2000-12-05	デュポンファーマシューティカルズカンパニー	アミジノフェニル―ピロリジン類、アミジノフェニル―ピロリン類、およびアミジノフェニル―イソオキサゾリジン類およびそれらの誘導体
US6057342A (en) *	1996-08-16	2000-05-02	Dupont Pharmaceutical Co.	Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
WO1999011657A1 (en) *	1997-08-29	1999-03-11	Proteus Molecular Design Ltd.	1-amino-7-isoquinoline derivatives as serine protease inhibitors
US6740682B2 (en)	1997-08-29	2004-05-25	Tularik Limited	Meta-benzamidine derivatives as serine protease inhibitors
JP2001515886A (ja)	1997-09-08	2001-09-25	ジョージタウン・ユニバーシティ	Ｐｋｃの置換された２−ピロリジノン活性化剤
AU736112B2 (en) *	1997-11-20	2001-07-26	Teijin Limited	Biphenylamidine derivatives
CA2333927A1 (en)	1998-04-01	1999-10-07	Dupont Pharmaceuticals Company	Pyrimidines and triazines as integrin antagonists
WO1999052861A1 (de) *	1998-04-09	1999-10-21	Institut für Diagnostikforschung GmbH an der Freien Universität Berlin	Neue benzylguanidinderivate für die therapie, in-vivo- und in-vitro-diagnostik
SK15072000A3 (sk)	1998-04-10	2001-08-06	Japan Tobacco Inc.	Amidové zlúčeniny
US6518305B1 (en)	1998-04-23	2003-02-11	Abbott Laboratories	Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6455571B1 (en)	1998-04-23	2002-09-24	Abbott Laboratories	Inhibitors of neuraminidases
IL138601A0 (en) *	1998-04-23	2001-10-31	Abbott Lab	Pyrrolidines as inhibitors of neuraminidases
ATE266662T1 (de) *	1998-07-22	2004-05-15	Daiichi Suntory Pharma Co Ltd	Nf-kappa b inhibitoren, die indanderivate als aktiven bestandteil enthalten
US6284796B1 (en) *	1998-08-06	2001-09-04	Abbott Laboratories	Ukokinase inhibitors
DE19844787A1 (de) *	1998-09-30	2000-04-13	Boehringer Ingelheim Pharma	Disubstituierte Pyrrolidinone, diese Verbindung enthaltende Arzneimittel und deren Verwendung sowie ihre Herstellung
WO2000051609A1 (en) *	1999-03-02	2000-09-08	Merck & Co., Inc.	3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
WO2000051607A1 (en)	1999-03-02	2000-09-08	Merck & Co., Inc.	3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
WO2000051610A1 (en) *	1999-03-02	2000-09-08	Merck & Co., Inc.	Pyrrolidine modulators of chemokine receptor activity
JP2002538151A (ja)	1999-03-02	2002-11-12	ベーリンガーインゲルハイムファーマシューティカルズインコーポレイテッド	カテプシンの可逆的インヒビターとして有用な化合物
US6420364B1 (en)	1999-09-13	2002-07-16	Boehringer Ingelheim Pharmaceuticals, Inc.	Compound useful as reversible inhibitors of cysteine proteases
RU2177317C1 (ru) *	2000-10-24	2001-12-27	Московский научно-исследовательский институт медицинской экологии (МНИИМЭ)	Производные хинолина для коррекции системы гемостаза, фармацевтическая композиция, средство для коррекции гемостаза
FR2817257B1 (fr) *	2000-11-30	2009-03-20	Sanofi Synthelabo	Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
CA2436774A1 (en) *	2001-01-30	2002-08-08	R. Michael Lawrence	Sulfonamide lactam inhibitors of factor xa
DE10121003A1 (de) *	2001-04-28	2002-12-19	Aventis Pharma Gmbh	Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
GB0114004D0 (en)	2001-06-08	2001-08-01	Glaxo Group Ltd	Chemical compounds
GB0114005D0 (en)	2001-06-08	2001-08-01	Glaxo Group Ltd	Chemical compounds
DK1397130T3 (da) *	2001-06-20	2007-11-12	Wyeth Corp	Substituerede indolsyrederivater som inhibitorer af plasminogenaktivatorinhibitor-1 (PAI-1)
TWI224101B (en) *	2001-06-20	2004-11-21	Wyeth Corp	Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
CN1726190A (zh) *	2002-12-10	2006-01-25	惠氏公司	作为纤溶酶原激活物抑制剂－1(pai－1)的抑制剂的取代3－羰基－1h－吲哚－1－基乙酸衍生物
ATE331708T1 (de) *	2002-12-10	2006-07-15	Wyeth Corp	Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen aktivator inhibitor-1 (pai-1) inhibitoren
UA80453C2 (en) *	2002-12-10	2007-09-25		Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
DK1569901T3 (da) *	2002-12-10	2009-02-16	Wyeth Corp	Aryl-, aryloxy- og alkoxysubstituerede 1H-indol-3-yl-glyoxylsyrederivater som inhibitorer af plasminogenaktivatorinhibitor-1 (PAI-1)
JP2006516593A (ja) *	2003-02-07	2006-07-06	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｍｍｐ−９依存性疾患の治療及び予防のためのジピリダモール又はモピダモールの使用
RU2005136383A (ru)	2003-04-24	2007-06-10	БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE)	Применение дипиридамола или мопидамола для лечения и предупреждения тромбоэмболических заболеваний и нарушений, вызываемыхизбыточным образованием и/или повышенным уровнем экспрессии тромбиновых рецепторов
EP1644346A1 (en) *	2003-05-16	2006-04-12	MERCK SHARP & DOHME LTD.	Cyclic sulfonamides for inhibition of gamma-secretase
US7265148B2 (en) *	2003-09-25	2007-09-04	Wyeth	Substituted pyrrole-indoles
US7442805B2 (en) *	2003-09-25	2008-10-28	Wyeth	Substituted sulfonamide-indoles
US7420083B2 (en) *	2003-09-25	2008-09-02	Wyeth	Substituted aryloximes
US7268159B2 (en) *	2003-09-25	2007-09-11	Wyeth	Substituted indoles
US7163954B2 (en) *	2003-09-25	2007-01-16	Wyeth	Substituted naphthyl benzothiophene acids
US7351726B2 (en) *	2003-09-25	2008-04-01	Wyeth	Substituted oxadiazolidinediones
US7534894B2 (en)	2003-09-25	2009-05-19	Wyeth	Biphenyloxy-acids
US7141592B2 (en) *	2003-09-25	2006-11-28	Wyeth	Substituted oxadiazolidinediones
US7342039B2 (en) *	2003-09-25	2008-03-11	Wyeth	Substituted indole oximes
US7582773B2 (en) *	2003-09-25	2009-09-01	Wyeth	Substituted phenyl indoles
US7446201B2 (en) *	2003-09-25	2008-11-04	Wyeth	Substituted heteroaryl benzofuran acids
US7411083B2 (en) *	2003-09-25	2008-08-12	Wyeth	Substituted acetic acid derivatives
US7332521B2 (en) *	2003-09-25	2008-02-19	Wyeth	Substituted indoles
EP1677783A2 (en)	2003-10-08	2006-07-12	Nicholas Piramal India Limited	Fibrinogen receptor antagonists and their use
WO2005080361A1 (en) *	2004-02-02	2005-09-01	Pfizer Products Inc.	Histamine-3 receptor modulators
WO2005108360A1 (en) *	2004-05-07	2005-11-17	Janssen Pharmaceutica N.V.	Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
KR20070055563A (ko) *	2004-08-23	2007-05-30	와이어쓰	혈전증 및 심혈관 질병의 치료에 유용한 플라스미노겐활성화제 억제제 타입-1(ｐａｉ-1)의 조절제로서의옥사졸로-나프틸 산
US7605172B2 (en) *	2004-08-23	2009-10-20	Wyeth	Thiazolo-naphthyl acids
BRPI0514549A (pt) *	2004-08-23	2008-06-17	Wyeth Corp	ácidos de pirrol-naftila como inibidores de pai-1
JP5208505B2 (ja) *	2004-08-30	2013-06-12	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	１１−ベータヒドロキシステロイドデヒドロゲナーゼ阻害剤としてのｎ−２アダマンタニル−２−フェノキシ−アセトアミド誘導体
JP5137574B2 (ja) *	2004-08-30	2013-02-06	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	１１−ベータヒドロキシステロイドヒドロゲナーゼ阻害剤としての三環式ラクタム誘導体
DE602005017159D1 (de)	2004-08-30	2009-11-26	Janssen Pharmaceutica Nv	Oxysteroid-dehydrogenase-inhibitoren
WO2006114096A1 (en) *	2005-04-25	2006-11-02	Danmarks Tekniske Universitet	Pyrrolidinone dipeptide analogs and use thereof as artificial sweeteners
US7683091B2 (en) *	2005-08-17	2010-03-23	Wyeth	Substituted indoles and methods of their use
WO2009045479A1 (en)	2007-10-05	2009-04-09	Acucela Inc.	Alkoxy compounds for disease treatment
KR20100086485A (ko) *	2007-10-23	2010-07-30	알러간, 인코포레이티드	치료적 치환된 락탐
EP4000610A1 (en)	2009-07-02	2022-05-25	Acucela Inc.	Pharmacology of visual cycle modulators
US20130267699A1 (en)	2011-06-24	2013-10-10	California Institute Of Technology	Quaternary heteroatom containing compounds
US8822679B2 (en) *	2011-06-24	2014-09-02	California Institute Of Technology	Quaternary heteroatom containing compounds
US9518034B2 (en)	2013-10-14	2016-12-13	California Institute Of Technology	Synthesis of chiral enaminones, their derivatives, and bioactivity studies thereof
EP3071541B1 (en)	2013-11-21	2023-06-07	Marquette University	Substituted (4'-hydroxyphenyl)cycloalkane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform
US10421696B2 (en)	2014-12-18	2019-09-24	California Institute Of Technology	Enantioselective synthesis of α-quaternary mannich adducts by palladium-catalyzed allylic alkylation
CA2981041C (en)	2015-03-27	2023-09-05	California Institute Of Technology	Asymmetric catalytic decarboxylative alkyl alkylation using low catalyst concentrations and a robust precatalyst
US10040784B2 (en)	2016-03-11	2018-08-07	California Institute Of Technology	Compositions and methods for acylating lactams
US10358422B2 (en)	2017-11-01	2019-07-23	California Institute Of Technology	Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols
EP3699173A1 (en)	2018-10-18	2020-08-26	California Institute of Technology	Gem-disubstituted pyrrolidines, piperazines, and diazepanes, and compositions and methods of making the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4247466A (en) *	1979-07-05	1981-01-27	American Cyanamid Company	Lactone metabolites of 3-(4-biphenylylcarbonyl)propionic acid
EP0194548A3 (de) *	1985-03-12	1988-08-17	Dr. Karl Thomae GmbH	Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
HU201300B (en) *	1985-03-16	1990-10-28	Wellcome Found	Process for production of derivatives of aryl and medical compositions containing them as active substance
DE3823299A1 (de) *	1988-07-07	1990-01-11	Schering Ag	Substituierte phenyl-pyrrolidin-2-one, -oxazolidin-2-one und -imidazolidin-2-one, ihre herstellung sowie verwendung in arzneimitteln

1990
- 1990-11-02 DE DE4035961A patent/DE4035961A1/de not_active Ceased
1991
- 1991-10-24 DK DK91118148T patent/DK0483667T3/da active
- 1991-10-24 EP EP91118148A patent/EP0483667B1/de not_active Expired - Lifetime
- 1991-10-24 AT AT91118148T patent/ATE163008T1/de not_active IP Right Cessation
- 1991-10-24 SG SG9601241A patent/SG81852A1/en unknown
- 1991-10-24 ES ES91118148T patent/ES2113867T3/es not_active Expired - Lifetime
- 1991-10-24 DE DE59108930T patent/DE59108930D1/de not_active Expired - Lifetime
- 1991-10-31 FI FI915136A patent/FI107606B/fi not_active IP Right Cessation
- 1991-10-31 PT PT99402A patent/PT99402B/pt not_active IP Right Cessation
- 1991-11-01 HU HU913455A patent/HUT67288A/hu unknown
- 1991-11-01 IL IL9992691A patent/IL99926A/en not_active IP Right Cessation
- 1991-11-01 RU SU915001905A patent/RU2040519C1/ru active
- 1991-11-01 NO NO914294A patent/NO174806B/no not_active IP Right Cessation
- 1991-11-01 JP JP3313154A patent/JP2937589B2/ja not_active Expired - Lifetime
- 1991-11-01 IE IE382291A patent/IE913822A1/en not_active IP Right Cessation
- 1991-11-01 CA CA002054850A patent/CA2054850C/en not_active Expired - Lifetime
- 1991-11-02 KR KR1019910019458A patent/KR100223135B1/ko not_active Expired - Lifetime
- 1991-11-04 NZ NZ240463A patent/NZ240463A/en not_active IP Right Cessation
- 1991-11-04 ZA ZA918734A patent/ZA918734B/xx unknown
1992
- 1992-06-29 MX MX9203677A patent/MX9203677A/es unknown
1994
- 1994-01-25 BG BG098416A patent/BG62025B2/bg unknown
- 1994-11-23 EE EE9400438A patent/EE03099B1/xx not_active IP Right Cessation
- 1994-12-28 US US08/365,336 patent/US5541343A/en not_active Expired - Lifetime
1995
- 1995-06-01 US US08/458,096 patent/US5591769A/en not_active Expired - Lifetime
- 1995-06-02 HU HU95P/P00156P patent/HU211563A9/hu unknown
1997
- 1997-05-06 BR BR1100445-2A patent/BR1100445A/pt active IP Right Grant
1998
- 1998-04-03 GR GR980400691T patent/GR3026508T3/el unknown

Also Published As

Publication number	Publication date
IL99926A0 (en)	1992-08-18
FI915136L (fi)	1992-05-03
MX9203677A (es)	1992-07-01
IL99926A (en)	1996-06-18
EP0483667B1 (de)	1998-02-04
US5591769A (en)	1997-01-07
AU8692691A (en)	1992-05-07
HU211563A9 (en)	1995-12-28
PT99402B (pt)	1999-04-30
DE59108930D1 (de)	1998-03-12
ATE163008T1 (de)	1998-02-15
DE4035961A1 (de)	1992-05-07
GR3026508T3 (en)	1998-07-31
HUT67288A (en)	1995-03-28
NO914294L (no)	1992-05-04
ES2113867T3 (es)	1998-05-16
EE03099B1 (et)	1998-06-15
HK1008742A1 (en)	1999-05-14
KR920009793A (ko)	1992-06-25
CA2054850A1 (en)	1992-05-03
NO174806B (no)	1994-04-05
AU650488B2 (en)	1994-06-23
EP0483667A2 (de)	1992-05-06
CA2054850C (en)	2001-01-02
PT99402A (pt)	1992-09-30
NZ240463A (en)	1997-04-24
BR1100445A (pt)	2000-07-18
HU913455D0 (en)	1992-01-28
JPH04264068A (ja)	1992-09-18
JP2937589B2 (ja)	1999-08-23
FI107606B (fi)	2001-09-14
ZA918734B (en)	1993-05-04
EP0483667A3 (en)	1992-09-16
BG62025B2 (bg)	1998-12-30
IE913822A1 (en)	1992-05-22
SG81852A1 (en)	2001-07-24
NO914294D0 (no)	1991-11-01
US5541343A (en)	1996-07-30
KR100223135B1 (ko)	1999-10-15
RU2040519C1 (ru)	1995-07-25
DK0483667T3 (da)	1998-09-23
FI915136A0 (fi)	1991-10-31

Legal Events

Date	Code	Title	Description
2011-11-14	MK1K	Patent expired

Publication	Publication Date	Title
NO174806C (cs)	1994-07-13
TW226377B (cs)	1994-07-11
TW232006B (cs)	1994-10-11
TW257753B (cs)	1995-09-21
IT1249062B (it)	1995-02-11	Derivati dell'eserolina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizuini farmaceutiche che li contengono.
IT1248068B (it)	1995-01-05	Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
MX9803556A (es)	1998-09-30	Derivados de aminoacidos, medicamentos que contienen tales compuestos y metodos para producirlos.